IRLAB Therapeutics, a Swedish Parkinson's disease treatment developer, will present at Life Science-dagen on March 6.
IRLAB Therapeutics, a Swedish Parkinson's disease treatment developer, will present at Life Science-dagen in Gothenburg on March 6. CFO Viktor Siewertz's presentation will be followed by a Q&A session and a fireside chat with ABG. IRLAB's pipeline, generated by its proprietary Integrated Screening Process (ISP), includes treatments for all stages of Parkinson's disease with several in Phase II and III trials.
February 29, 2024
4 Articles